Stocks
Intellia Therapeutics (NTLA) P/S US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 253.6 | 51.5 | 74.6 | 19.9 | 14.4 | 24.5 | ||
| Changes by years, y/y, % | +383% | -80% | +45% | -73% | -28% | -22.8% | |||
Intellia Therapeutics. P/S
Intellia Therapeutics. P/S, changes, %
Intellia Therapeutics (NTLA) P/S US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/S | ? | 16.1 | 18.4 | 33.1 | 14.4 | 23.0 | 24.5 | |
| Changes by years, y/y, % | -68% | -61% | -31% | -30% | +42% | |||
| Changes by quarters, q/q, % | -21% | +14% | +80% | -56% | +60% | |||
